Abstract:Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation, engendering transcript diversity, and modifications in protein structure and functionality. Across varying tissues, developmental stages, or under specific conditions, AS gives rise to distinct splice isoforms. This implies that these isoforms possess unique temporal and spatial roles, thereby associating AS with standard biological activities and diseases. Among these, AS-related RNA-binding proteins (RBPs) play an instrumental role in regulating alternative splicing events. Under physiological conditions, the diversity of proteins mediated by AS influences the structure, function, interaction, and localization of proteins, thereby participating in the differentiation and development of an array of tissues and organs. Under pathological conditions, alterations in AS are linked with various diseases, particularly cancer. These changes can lead to modifications in gene splicing patterns, culminating in changes or loss of protein functionality. For instance, in cancer, abnormalities in AS and RBPs may result in aberrant expression of cancer-associated genes, thereby promoting the onset and progression of tumors. AS and RBPs are also associated with numerous neurodegenerative diseases and autoimmune diseases. Consequently, the study of AS across different tissues holds significant value. This review provides a detailed account of the recent advancements in the study of alternative splicing and AS-related RNA-binding proteins in tissue development and diseases, which aids in deepening the understanding of gene expression complexity and offers new insights and methodologies for precision medicine.

RNA structure in alternative splicing regulation: from mechanism to therapy

RNA Structures in Alternative Splicing and Back‐splicing

<scp>RNA</scp> structures in alternative splicing and back‐splicing

Role of RNA Secondary Structures in Regulating Dscam Alternative Splicing

Cooperation and Competition of RNA Secondary Structure and RNA–Protein Interactions in the Regulation of Alternative Splicing

New insights into RNA secondary structure in the alternative splicing of pre-mRNAs

Aberrant splicing in human cancer: An RNA structural code point of view

Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches

Conservation and Regulation of Alternative Splicing by Dynamic Inter- and Intra-Intron Base Pairings in Lepidoptera 14-3-3z Pre-Mrnas

Epigenetic Regulation of Alternative Splicing.

Alternative pre-mRNA splicing in stem cell function and therapeutic potential: A critical review of current evidence

Approaches to link RNA secondary structures with splicing regulation

Alternative splicing and related RNA binding proteins in human health and disease

An RNA architectural locus control region involved in Dscam mutually exclusive splicing

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer

Therapeutic potential of alternative splicing in cardiovascular diseases

Alternative splicing and cancer: a systematic review

RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases

RNA secondary structure in mutually exclusive splicing

Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects

Splicing Dysregulation in Cancer: from Mechanistic Understanding to a New Class of Therapeutic Targets